Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Analytik Jena AG. (9/4/13). "Press Release: Analytik Jena AG Approves a Subscription Rights Capital Increase of up to 1.95 Million New Shares (Ad-hoc notification in accordance with Section 15 WpHG [Securities Trading Act])". Jena.

Organisations Organisation Analytik Jena AG
  Group Endress+Hauser (Group)
  Organisation 2 Endress+Hauser AG
  Group Endress+Hauser (Group)
Products Product analytical instrument
  Product 2 diagnostics (medical/biological)
Index terms Index term Analytik Jena–SEVERAL: investment, 201309 capital increase €24.4m €23.4m net 1.95m new shares €12.5/share exlusively to existent shareholders
  Index term 2 Analytik Jena–Endress+Hauser: investment, 201309 capital increase €24.4m incl Endress+Hauser with resulting direct + indirect 47.33% share for E+H
Person Person Schmidt, Dana (Analytik Jena 201107 Media Relations)
     


Today the Executive Board of Analytik Jena AG ("Analytik Jena" Prime Standard: AJA, ISIN: DE0005213508) with the approval of the Supervisory Board has passed a resolution to issue up to 1,950,232 New Shares through a capital increase against cash contributions with subscription rights for shareholders. The subscription ratio will amount to 3:1, meaning that three shares of Analytik Jena equate a subscription right to one New Share. The subscription price was set at EUR 12.50 per New Share. The New Shares will already be entitled to profit participation for financial year 2012/2013. The subscription offer will begin on September 6, 2013, 0:00 AM and end on September 19, 2013, 24:00 PM. IKB Deutsche Industriebank AG will manage the capital increase.

The subscription offer is addressed exclusively to the previous shareholders of Analytik Jena. Exchange trading of subscription rights is not provided. Aside from the subscription offer, the transaction will not involve any additional offers of New Shares, particularly no private placement.

Already prior to the beginning of the subscription offer, Ruesch Holding AG, Unterägeri, Switzerland, has committed to acquiring all New Shares which have not been exercised by the holders of subscription rights during the offer. Analytik Jena therefore assumes that the capital increase will be executed in its entirety. Endress+Hauser AG, Analytik Jena's largest shareholder, has informed Analytik Jena that Ruesch Holding AG will transfer the New Shares it acquires to a group company of Endress+Hauser AG, after the Bundeskartellamt (German Federal Cartel Office) has issued antitrust authorization for this transfer. If antitrust authorization is denied, Ruesch Holding AG will resell the acquired New Shares at the best possible price to third parties.

Analytik Jena intends to use the expected net proceeds of approximately EUR 23.4 million for various purposes. These purposes include strengthening the equity base, improving liquidity, and ensuring compliance with financial covenants from bond and loan agreements. Furthermore Analytik Jena intends to use portions of the proceeds for potential corporate acquisitions, for expanding the research and development area through cooperative research agreements, for building up and expanding its own international sales structures, and for restructuring subsidiaries.

Upon completion of the capital increase, the registered share capital will increase from approximately EUR 5.71 million currently to approximately EUR 7.66 million. The capital increase is expected to be recorded into the commercial register on September 23, 2013. The New Shares are to be approved for exchange trading on the same day. The listing and delivery of the New Shares are scheduled for September 24, 2013. The execution of the capital increase is contingent on approval of the security prospectus by the German Federal Financial Supervisory Authority (BaFin), which is expected on September 5, 2013.

Contact

Dana Schmidt
Press Spokeswoman+49 (0) 36 41 77-92 81press@analytik-jena.com

   
Record changed: 2017-04-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Endress+Hauser (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px